Related Experiment Video
Updated: May 12, 2026
09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
Thrombosis in paroxysmal nocturnal hemoglobinuria
Anita Hill1, Richard J Kelly, Peter Hillmen
1Department of Haematology, St. James's University Hospital, Leeds, United Kingdom. anitahill@nhs.net
Blood
|April 24, 2013
Summary
Thrombosis, a major complication of paroxysmal nocturnal hemoglobinuria (PNH), is linked to the interplay between complement and coagulation systems. Complement inhibition effectively prevents and manages thrombosis in PNH patients.
Area of Science:
- Hematology
- Immunology
- Vascular Biology
Background:
- Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by a high risk of thrombosis.
- The complement and coagulation systems are intricately linked, influencing thrombosis in PNH.
- Thrombin can activate the alternative complement pathway, contributing to thrombotic complexity in PNH.
Purpose of the Study:
- To review recent advances in understanding the pathophysiology of thrombosis in PNH.
- To discuss current treatment strategies for thrombosis in PNH.
- To explore the mechanisms underlying thrombosis in PNH.
Main Methods:
- Review of recent scientific literature on PNH pathophysiology and thrombosis.
- Analysis of mechanisms including platelet activation, free hemoglobin toxicity, nitric oxide depletion, and endothelial dysfunction.
- Evaluation of the role of glycosylphosphatidylinositol-linked proteins.
Main Results:
- The close integration of complement and coagulation systems contributes to thrombosis in PNH.
- Multiple mechanisms, including platelet activation and nitric oxide depletion, are implicated in PNH thrombosis.
- Complement inhibition, specifically with eculizumab, significantly impacts thrombosis prevention and management.
Conclusions:
- Understanding the complex pathophysiology of thrombosis in PNH is crucial for effective management.
- Targeting the complement system offers a promising therapeutic strategy for reducing thrombotic risk in PNH.
- Eculizumab demonstrates significant efficacy in preventing and treating thrombosis in PNH.
Related Concept Videos
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...